Brief: Centessa Pharmaceuticals Announces Pricing Of $250,000,000 Public Offering Of American Depositary Shares
12/11/2025 01:42
Centessa Pharmaceuticals PLC 260y.F: CENTESSA PHARMACEUTICALS ANNOUNCES PRICING OF $250,000,000 PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES CENTESSA PHARMACEUTICALS PLC - PRICING OF 11.6 MILLION AMERICAN DEPOSITARY SHARES, AT A PRICE TO PUBLIC OF $21.50 PER ADS Source text: ID:nGNEbhl5bF Further company coverage: [260y.F]
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1